异构卵性原血突变 - 相关的血栓友爱症
Xi Wu1, Lei Li1, Zhengjing Lu1
1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Thrombosis and haemostasis
|June 24, 2024
概括
异性前列血突变与静脉血栓塞栓症 (VTE) 的风险增加有关. 这些遗传变异通过影响抗血抗性和C蛋白激活来增强血块形成.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 遗传性血栓ophilia 通过血栓突变使个体易患静脉血栓栓塞 (VTE).
- 虽然 homozygous prothrombin 突变会导致出血,但异构的形式很少与血栓形成有关.
- 这项研究调查了与异性前突变相关的血栓风险.
研究的目的:
- 在未引起VTE或血栓形成家族病史的患者中识别和表征异构性前列血突变.
- 通过家族调查和功能分析,阐明这些突变背后的血栓机制.
- 评估突变载体中的高凝血性和血栓生成潜力.
主要方法:
- 对347名患者进行血栓形成和血静变异的遗传查.
- 对于异胞性前突变载体的家族调查和血栓生成试验 (TGT).
- 新型突变的功能测试,以确定它们对血栓激素活性和C蛋白激活的影响.
主要成果:
- 在3.5%的患者中发现了异性前突变,包括三个新突变 (Phe382Ser,Phe382Leu,Asp597Tyr) 和之前报告的突变 (Arg541Trp,Arg596Gln).
- 在42个已识别的突变载体中,64.3%的人经历了血栓事件.
- 在载体中,TGT显示出高凝血性,Arg596Gln和Arg541Trp显示出最大的血栓生成率. Phe382突变损害了蛋白C的激活,而Asp597Tyr显示了抗血素不激活和蛋白C激活的轻微减少.
结论:
- 异构性前突变是VTE的潜在遗传风险因素.
- 这些突变通过抵抗抗血或损害蛋白C通路活性来增加凝血活性.
- 了解这些机制对于评估受影响个体的血栓形成风险至关重要.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
01:24Disorders of Hemostasis
831
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
831
01:49Probability Laws
40.8K
Overview
40.8K
01:49Multiple Allele Traits
34.2K
The Concept of Multiple Allelism
34.2K